Toulouse, France

Bernard Payrastre

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Regional Universitaire De Caen, Centre Hospitalier Universitaire De Toulouse, National Institute of Health and Medical Research. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard Payrastre. Retrieved from https://idiyas.com/inventor/bernard-payrastre-owewldx1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bernard Payrastre

Introduction

Bernard Payrastre is a notable inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in understanding and addressing ischemic conditions. His work focuses on preserving vascular endothelial cell barrier integrity, which is crucial for patient recovery following ischemic events.

Latest Patents

Bernard Payrastre holds a patent for the "Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity." This invention addresses the critical issue of ischemia, a condition characterized by reduced blood flow and oxygen to an organ. The patent highlights the importance of re-establishing blood flow and re-oxygenation after an ischemic episode to limit irreversible damage. However, it also acknowledges the potential damaging consequences of reperfusion, such as increased vascular permeability, which contributes to edema and tissue damage. Payrastre's research demonstrates that genetic inhibition of PI3K-C2β reduces cerebral infarction in two ischemia/reperfusion models and improves neurological outcomes. This genetic inhibition stabilizes the blood-brain barrier after ischemic stroke and reduces inflammation. The invention provides a method for preserving vascular endothelial cell barrier integrity in patients by administering a therapeutically effective amount of a PI3KC2β inhibitor.

Career Highlights

Throughout his career, Bernard Payrastre has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and Université Paul Sabatier Toulouse III. His research has significantly advanced the understanding of ischemic conditions and the mechanisms involved in vascular integrity.

Collaborations

Some of his notable collaborators include Marie-Pierre Gratacap and Jean Darcourt. Their combined efforts have contributed to the advancements in medical research and the development of innovative solutions for ischemic conditions.

Conclusion

Bernard Payrastre's work exemplifies the impact of innovative research in the medical field. His contributions to understanding ischemic conditions and developing therapeutic methods highlight the importance of preserving vascular integrity for patient recovery. His patent and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…